

VIZZ is an eye drop that contains aceclidine ophthalmic solution 1.44%, designed for adults experiencing presbyopia, the age-related loss of near vision. It was FDA-approved on July 31, 2025, and is available by prescription only.
Presbyopia occurs when the eye’s lens becomes less flexible with age, making it harder to focus on nearby objects. VIZZ helps improve near vision for everyday activities such as:
Compared to previously available drops VIZZ offers key differences:
VIZZ improves near vision, but many patients may still need reading glasses in:
VIZZ works by reducing the size of the pupil, creating a pinhole effect that sharpens near vision clarity without effecting the distance vision.
No. VIZZ is currently a cash-pay treatment.
Yes. Many patients continue wearing their distance contact lenses and use VIZZ to improve near vision. Be sure to:
Yes, but near vision benefits may be limited, particularly in patients over age 60. Most post-cataract patients will still need reading glasses, even when using VIZZ, however a comprehensive eye exam is needed to ensure retinal health prior to use.
Yes. Patients who have had LASIK may benefit from VIZZ depending on their age and the severity of their presbyopia, however a comprehensive eye exam is needed to ensure retinal health prior to use.
Most side effects are mild and temporary. The most commonly reported include:
A VIZZ evaluation Advanced Optometry of Mission Viejo involves a dilated eye exam to ensure adequate retinal health and a sample box to try VIZZ in your every day life.